Antihypertensive safety and efficacy and physician and patient satisfaction: results from a phase 4 practice-based clinical experience trial with diltiazem LA-Reference-Cited by-同舟云学术

Antihypertensive safety and efficacy and physician and patient satisfaction: results from a phase 4 practice-based clinical experience trial with diltiazem LA

Published:2006-03 Issue:2 Volume:23 Page:284-294
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Glasser Stephen P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02850134.pdf

Reference27 articles.

1. Buckley MM, Grant SM, Goa KL, et al. Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.Drugs. 1990; 39: 757–806.

2. Cardizem LA (diltiazem HCL) [package insert]. Bridgewater, NJ: Biovail Pharmaceuticals, Inc.; 2004.

3. Sista S, Lai JC, Eradiri O, Albert KS. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.J Clin Pharmacol. 2003; 43: 1149–1157.

4. Prisant LM. Chronotherapeutics: a surge of ideas.Clin Cornerstone. 2004; 6: 7–17.

5. Glasser SP, Neutel JM, Gana TJ, Albert KS. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.Am J Hypertens. 2003; 16: 51–58.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and characterization of a novel once-daily formulation of diltiazem using arabinogalactan as a channeling agent;Journal of Applied Polymer Science;2012-04-01

2. Diltiazem in the treatment of hypertension and ischemic heart disease;Expert Review of Cardiovascular Therapy;2011-11

3. Chemical and Biological Approaches for Adapting Proteostasis to Ameliorate Protein Misfolding and Aggregation Diseases-Progress and Prognosis;Cold Spring Harbor Perspectives in Biology;2011-09-07

4. Importance and Challenges of Studying Marketed Drugs: What Is a Phase IV Study? Common Clinical Research Designs, Registries, and Self-Reporting Systems;The Journal of Clinical Pharmacology;2007-09

5. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2006